The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism | Zendy

Torben Harsløf | Zendy; Tanja Sikjær | Zendy; Lotte Sørensen | Zendy; Steen B. Pedersen | Zendy; Leif Mosekilde | Zendy; Bente Langdahl | Zendy; Lars Rejnmark | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism

Author(s) -

Torben Harsløf,

Tanja Sikjær,

Lotte Sørensen,

Steen B. Pedersen,

Leif Mosekilde,

Bente Langdahl,

Lars Rejnmark

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-1477

Subject(s) - endocrinology , medicine , osteocalcin , placebo , parathyroid hormone , bone remodeling , glucose homeostasis , carbohydrate metabolism , insulin resistance , hypoparathyroidism , insulin , biology , calcium , alkaline phosphatase , biochemistry , alternative medicine , pathology , enzyme

Undercarboxylated osteocalcin (ucOC) has been shown to affect glucose metabolism in mice. We recently randomized patients with hypoparathyroidism to treatment with PTH or placebo and demonstrated a marked increase in total osteocalcin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research